Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Atmospheric Control Unit - Control O2 and CO2 within the Microplate Reader

Product Description
acu-background-200.jpgBMG LABTECH offers a dual gas control feature on all Omega series microplate readers, as well as the NEPHELOstar Plus. The Atmospheric Control Unit (ACU) independently controls and regulates both CO2 and O2 to effectively control the internal atmosphere of the microplate chamber.

The proprietary design of the microprocessor controlled Atmospheric Control Unit provides the highest level of atmospheric flexibility by incorporating dual independent control of both CO2 and O2. This eliminates the need for costly pre-mixed gas tanks and expands the range of possible atmospheric gas ratios. Each control valve is regulated to ensure precise gas measurements. The oxygen can be monitored from 1-19% and CO2 can be accurately adjusted between 0-20%.
The Atmospheric Control Unit is compatible with all Omega series microplate readers, as well as the NEPHELPstar Plus nephelometer. The ACU provides a solution to all atmosphere sensitive assays, including:

• Mammalian and Stem Cell Assays
• Hypoxia
• Cell Viability
• Cell Growth
• Migration Studies
• Invasion Assays
• Intracellular pH
• Angiogenesis
• Viral Uptake
• Bacterial Studies
• Ischemia / Reperfusion and mor
Product Atmospheric Control Unit - Control O2 and CO2 within the Microplate Reader
Company BMG Labtech GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BMG Labtech GmbH
Allmendgruen 8, 77799 Ortenberg Germany

Tel: +49 781 96968-0
Fax: +49 781 96968-67
Email: hts@bmglabtech.com



Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!